Evidence map›Paper›PMID 42465815›Full record

ArticleACG case reports journal2026

Malignant Hepatic Infiltration Versus Drug-Induced Liver Injury in B-Cell Acute Lymphoblastic Leukemia.

Jeffrey Liu, Arpine Petrosyan, Jennifer Yoon, Marina Roytman

Abstract readCase Reports
In one paragraph

Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeffrey LiuDepartment of Internal Medicine, University of California San Francisco School of Medicine, Fresno, CA.ORCID https://orcid.org/0000-0002-5410-6922
Arpine PetrosyanDivision of Gastroenterology and Hepatology, University of California San Francisco School of Medicine, Fresno, CA.
Jennifer YoonDivision of Gastroenterology and Hepatology, University of California San Francisco School of Medicine, Fresno, CA.
Marina RoytmanDivision of Gastroenterology and Hepatology, University of California San Francisco School of Medicine, Fresno, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell acute lymphoblastic leukemia (B-ALL) is the most common subtype of lymphoid malignancy. Elevated liver enzymes in B-ALL may reflect both hepatic infiltration and chemotherapy-related drug-induced liver injury. This creates a diagnostic challenge that can be delineated with a liver biopsy, preventing delays in management and care. We present 2 patients with B-ALL who developed elevated liver enzymes during chemotherapy and underwent liver biopsy demonstrating hepatic infiltration. These biopsy-proven cases highlight the critical role of liver biopsy in distinguishing hepatic infiltration from drug-induced liver injury, guiding management decisions and allowing for continued chemotherapy without unnecessary delay.

Indexed as

DILIliverlymphoblastic leukemialymphocytes

Identifiers

PMID42465815
PMCPMC13375062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.